p21-话题@MedSci

#p21#

16篇内容 | 748人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2221324, encodeId=897b2221324d0, content=<a href='/topic/show?id=f9e046e64a7' target=_blank style='color:#2F92EE;'>#寿命#</a> <a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a> <a href='/topic/show?id=812788522b7' target=_blank style='color:#2F92EE;'>#虚弱#</a>, objectTitle=长寿新突破，新型疗法或能让人们健康活到130岁！Cell Metab：定期清除高度表达p21的细胞不仅让小鼠延长寿命，而且活得更健康, objectType=article, longId=839524, objectId=145483952450, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20240818/1723963916301_2185383.png, objectUrl=/article/show_article.do?id=145483952450, replyNumber=0, likeNumber=28, createdTime=2024-08-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1786035, encodeId=ae461e8603544, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=BLOOD：PP2A是在急性髓系白血病中通过 c-Myc/p21 轴决定细胞命运的可治疗靶向驱动因素, objectType=article, longId=220764, objectId=bce1220e6463, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bce1220e6463, replyNumber=0, likeNumber=99, createdTime=2021-12-09, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bce1220e6463, moduleTitle=BLOOD：PP2A是在急性髓系白血病中通过 c-Myc/p21 轴决定细胞命运的可治疗靶向驱动因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bce1220e6463)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786034, encodeId=238c1e8603486, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=J INTERN MED：较高针对apoB100 p210的自身抗体水平与女性较低的房颤发生率相关, objectType=article, longId=217314, objectId=c92e21e314b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c92e21e314b2, replyNumber=0, likeNumber=75, createdTime=2021-10-06, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c92e21e314b2, moduleTitle=J INTERN MED：较高针对apoB100 p210的自身抗体水平与女性较低的房颤发生率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c92e21e314b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786033, encodeId=62cd1e860332a, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=Gastroenterology：核酸聚合物REP 2139/REP2165、替诺福韦联合干扰素可提高HBV治疗效果, objectType=article, longId=196774, objectId=af68196e7496, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af68196e7496, replyNumber=0, likeNumber=73, createdTime=2020-08-04, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af68196e7496, moduleTitle=Gastroenterology：核酸聚合物REP 2139/REP2165、替诺福韦联合干扰素可提高HBV治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af68196e7496)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786032, encodeId=02611e8603251, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=IJLH：通过RT- qPCR对p210 BCR‐ABL1转录本进行定量的外部质量评估的结果和建议, objectType=article, longId=167536, objectId=644016e536c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=644016e536c0, replyNumber=0, likeNumber=80, createdTime=2019-12-10, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=644016e536c0, moduleTitle=IJLH：通过RT- qPCR对p210 BCR‐ABL1转录本进行定量的外部质量评估的结果和建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=644016e536c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786031, encodeId=89eb1e860316d, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, objectType=article, longId=160191, objectId=ae36160191ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae36160191ca, replyNumber=0, likeNumber=82, createdTime=2019-10-18, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae36160191ca, moduleTitle=病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae36160191ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786030, encodeId=f2d01e86030ff, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=Haematologica：病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, objectType=article, longId=160125, objectId=f00f160125bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f00f160125bf, replyNumber=0, likeNumber=79, createdTime=2019-12-10, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f00f160125bf, moduleTitle=Haematologica：病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f00f160125bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786029, encodeId=f4c31e86029a1, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=INT J LAB HEMATOL：qPCR定量p210 BCR ABL1转录本的外部质量评价如何？, objectType=article, longId=159022, objectId=20ef15902226, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20ef15902226, replyNumber=0, likeNumber=88, createdTime=2019-11-12, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20ef15902226, moduleTitle=INT J LAB HEMATOL：qPCR定量p210 BCR ABL1转录本的外部质量评价如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20ef15902226)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786028, encodeId=9ff71e860286b, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=JCLA：BCR ABL1p210/p190融合基因转录本定量的方法的制定和评价, objectType=article, longId=158383, objectId=205a158383ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=205a158383ee, replyNumber=0, likeNumber=78, createdTime=2019-02-20, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=205a158383ee, moduleTitle=JCLA：BCR ABL1p210/p190融合基因转录本定量的方法的制定和评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=205a158383ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786024, encodeId=baab1e8602472, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=Oncotarget：lincRNA-p21有作为胃癌潜在生物标志物和重要治疗靶点的潜力, objectType=article, longId=107517, objectId=1f3d10e517a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f3d10e517a4, replyNumber=0, likeNumber=75, createdTime=2017-09-13, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f3d10e517a4, moduleTitle=Oncotarget：lincRNA-p21有作为胃癌潜在生物标志物和重要治疗靶点的潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f3d10e517a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786027, encodeId=70de1e86027e3, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=Int J Mol Med：低剂量放射可以通过ATM/p21信号通路抑制人类p53null类型前列腺癌细胞的增殖, objectType=article, longId=120868, objectId=4b3512086845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b3512086845, replyNumber=0, likeNumber=66, createdTime=2018-08-19, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b3512086845, moduleTitle=Int J Mol Med：低剂量放射可以通过ATM/p21信号通路抑制人类p53null类型前列腺癌细胞的增殖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b3512086845)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786025, encodeId=aba11e860250d, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=Onco Targets Ther：研究揭示LincRNA-p21抑制肝癌细胞迁移及侵袭的机制, objectType=article, longId=115125, objectId=be5c11512561, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be5c11512561, replyNumber=0, likeNumber=83, createdTime=2018-01-03, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be5c11512561, moduleTitle=Onco Targets Ther：研究揭示LincRNA-p21抑制肝癌细胞迁移及侵袭的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be5c11512561)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786026, encodeId=68951e860265a, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=Sci Rep：TGF-β诱导的肝细胞lincRNA-p21可促进肝纤维化的发生, objectType=article, longId=115149, objectId=ecbf11514956, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecbf11514956, replyNumber=0, likeNumber=80, createdTime=2018-09-03, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecbf11514956, moduleTitle=Sci Rep：TGF-β诱导的肝细胞lincRNA-p21可促进肝纤维化的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecbf11514956)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786023, encodeId=f44b1e860232d, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=重磅：2016年全新发布高血压指南 TOP21, objectType=article, longId=85148, objectId=9730851488a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9730851488a, replyNumber=0, likeNumber=70, createdTime=2017-03-11, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9730851488a, moduleTitle=重磅：2016年全新发布高血压指南 TOP21, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9730851488a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786022, encodeId=badc1e8602243, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=Hepatology：肝癌潜在治疗靶点：DUSP21, objectType=article, longId=23211, objectId=a1252321157, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1252321157, replyNumber=0, likeNumber=81, createdTime=2014-03-10, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1252321157, moduleTitle=Hepatology：肝癌潜在治疗靶点：DUSP21, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1252321157)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786021, encodeId=961a1e86021e8, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=Cell Stem Cell：p53/p21在范可尼氏贫血病中的独特作用, objectType=article, longId=7083, objectId=e3afe08347, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3afe08347, replyNumber=0, likeNumber=88, createdTime=2013-03-04, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3afe08347, moduleTitle=Cell Stem Cell：p53/p21在范可尼氏贫血病中的独特作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3afe08347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1786020, encodeId=21261e86020e9, content=<a href='/topic/show?id=48f613605c4' target=_blank style='color:#2F92EE;'>#p21#</a>, objectTitle=JBC：发现新的p53-p21通路的调节因子, objectType=article, longId=5599, objectId=b6625599ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6625599ed, replyNumber=0, likeNumber=97, createdTime=2013-02-06, rootId=0, userName=tulenzi, userId=54f9127, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6625599ed, moduleTitle=JBC：发现新的p53-p21通路的调节因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6625599ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

p21

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#寿命# #p21# #虚弱#

2024-08-19发表于上海

tulenzi (审核中...)

前往app查看评论内容

#p21#

BLOOD：PP2A是在急性髓系白血病中通过 c-Myc/p21 轴决定细胞命运的可治疗靶向驱动因素

2021-12-09

tulenzi (审核中...)

前往app查看评论内容

#p21#

J INTERN MED：较高针对apoB100 p210的自身抗体水平与女性较低的房颤发生率相关

2021-10-06

tulenzi (审核中...)

前往app查看评论内容

#p21#

Gastroenterology：核酸聚合物REP 2139/REP2165、替诺福韦联合干扰素可提高HBV治疗效果

2020-08-04

tulenzi (审核中...)

前往app查看评论内容

#p21#

IJLH：通过RT- qPCR对p210 BCR‐ABL1转录本进行定量的外部质量评估的结果和建议

2019-12-10

tulenzi (审核中...)

前往app查看评论内容

#p21#

病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1

2019-10-18

tulenzi (审核中...)

前往app查看评论内容

#p21#

Haematologica：病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1

2019-12-10

tulenzi (审核中...)

前往app查看评论内容

#p21#

INT J LAB HEMATOL：qPCR定量p210 BCR ABL1转录本的外部质量评价如何？

2019-11-12

tulenzi (审核中...)

前往app查看评论内容

#p21#

JCLA：BCR ABL1p210/p190融合基因转录本定量的方法的制定和评价

2019-02-20

tulenzi (审核中...)

前往app查看评论内容

#p21#

Oncotarget：lincRNA-p21有作为胃癌潜在生物标志物和重要治疗靶点的潜力

2017-09-13

tulenzi (审核中...)

前往app查看评论内容

#p21#

Int J Mol Med：低剂量放射可以通过ATM/p21信号通路抑制人类p53null类型前列腺癌细胞的增殖

2018-08-19

tulenzi (审核中...)

前往app查看评论内容

#p21#

Onco Targets Ther：研究揭示LincRNA-p21抑制肝癌细胞迁移及侵袭的机制

2018-01-03

tulenzi (审核中...)

前往app查看评论内容

#p21#

Sci Rep：TGF-β诱导的肝细胞lincRNA-p21可促进肝纤维化的发生

2018-09-03

tulenzi (审核中...)

前往app查看评论内容

#p21#

重磅：2016年全新发布高血压指南 TOP21

2017-03-11

tulenzi (审核中...)

前往app查看评论内容

#p21#

Hepatology：肝癌潜在治疗靶点：DUSP21

2014-03-10

tulenzi (审核中...)

前往app查看评论内容

#p21#

Cell Stem Cell：p53/p21在范可尼氏贫血病中的独特作用

2013-03-04

tulenzi (审核中...)

前往app查看评论内容

#p21#

JBC：发现新的p53-p21通路的调节因子

2013-02-06

科室
- - 订阅+
  - 更多科室
工具
服务